The leaders of Japan and China got off to a tense start but have made significant progress in turning around their relations in recent years.Asia Politicsread more
Tech's hottest IPOs of the year, including Beyond Meat and Zoom, dropped on Monday, falling more than the broader market.Technologyread more
Stocks in Asia slipped in Tuesday afternoon trade, while investors looked toward a meeting between U.S. President Donald Trump and Chinese President Xi Jinping set to happen...Asia Marketsread more
A week of dovish fireworks out of the central banking community has just gone by with most of the world's leading central banks now guiding towards easing in light of downside...Commentaryread more
"We do not seek conflict with Iran or any other country," Trump tells reporters in the Oval Office.Politicsread more
Chinese Vice Premier Liu He held a phone conversation with U.S. Trade Representative Robert Lighthizer and U.S. Treasury Secretary Steven Mnuchin, China's Ministry of Commerce...World Economyread more
Sen. Bernie Sanders announced a plan Monday to forgive the country's $1.6 trillion outstanding student loan tab, intensifying the higher education policy debate in the 2020...Personal Financeread more
While earnings usually come in substantially ahead of expectations — as much as 4 or 5 percentage points is not unusual — the downward direction in the outlook doesn't speak...Earningsread more
U.S. President Donald Trump's senior adviser Kellyanne Conway will not testify before the House of Representatives Oversight Committee this week on her alleged violations of...Politicsread more
"We missed being the dominant mobile operating system by a very tiny amount. We were distracted during our antitrust trial. We didn't assign the best people to do the work,"...Technologyread more
PatientsLikeMe was bought by UnitedHealth following a review by Trump's Treasury Department, which scrutinized the start-up because it's backed by Chinese cash.Technologyread more
Anadarko Petroleum: "We sold that one for the charitable trust. It is time to move on, my friend."
CVS Health: CEO Larry Merlo has "a big analyst meeting coming up and he's gotta explain how he's gonna be able to cut down that debt, pay down debt, and if he does that, then people would buy it. But I do not [recommend it] ahead of that analyst meeting. We gotta see what he says."
Lowe's: "I thought that [CEO] Marvin Ellison — I thought he explained himself very well ... He's working really hard to be able to get the place in shape, and no one has the conviction to stay with him except for me. I think if you buy that stock at $90, you're gonna make a good buy. And Marvin, please come on this show because you know how to tell the story."
CymaBay Therapeutics: "Don't know that bad boy. We're gonna have to do some work."
USA Technologies: "We need to know more about why that stock got hammered."
bluebird bio: "I think it's a great spec. I really do. I think it's got marvelous technology and it would not shock me if somebody did buy them."
Intuitive Surgical: "This stock has come under severe selling. Dave, I bet if you buy this and put it away ... you're gonna have a good one."
Micron Technology: "Here's a stock that gives up a few points every single day. This is where it bottomed last time. I think Micron is $3 down and $10 up. I've got $3 [down] happening first."